Skip to main content
S&P 5007,656.98+0.86%DOW52,573.29+0.98%NASDAQ26,333.03+0.96%BTC$77,267.00+0.58%ETH$2,510.86+2.27%GOLD$4,390.00-0.39%OIL$99.99-2.43%
Smart Investors Daily
TO

NASDAQ · TOIIW

The Oncology Institute, Inc.

Healthcare · Medical - Care Facilities

$0.05

Down-$0.00 (-3.27%)

Updated Sep 13, 2026, 9:00 PM

SID Score

3.7/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
14.76M
P/E ratio
-55.37
Dividend yield
0.00%
52-week range
$0.03 – $0.09
Volume
901
Avg. volume
22.11K

Price performance

TOIIW price history

1M range · 0 trading sessions · Daily adjusted prices

TOIIW does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest TOIIW news

The latest Smart Investors Daily articles mentioning TOIIW.

Stock researchCompany · Overview

TOIIW research

Overview

Company profile and research snapshot.

Company profile

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Aug 3, 2026

The Oncology Institute Rebrands as Starling Oncology

Company to begin trading on Nasdaq under new ticker symbol “STLN,” replacing “TOI”CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or “the Company”), one of the largest value-based oncology groups in the United States, announced today that it has rebranded to “Starling Oncology, Inc.™.” The Company's common stock will begin trading under the new ticker symbol "STLN” on Nasdaq, effective August 4, 2026, replacing its previous ticker symbol “TOI.” “We've spen

Yahoo · Jul 27, 2026

The Oncology Institute Announces Second Quarter 2026 Earnings Release Date and Conference Call

CERRITOS, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release its second quarter 2026 financial results on Thursday, August 6, 2026, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-833-316-1983 or, for international callers, 1-785-838-9310, and referencing Confere

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By